Additionally, based on our results, RA patients treated with tumor necrosis factor (TNF)-α-inhibitors, interleukin (IL)-6-inhibitor had reduced SARS-CoV-2-specific antibody response and anti-CD20 therapy inhibited both SARS-CoV-2-induced humoral and cellular immune responses (19). The gene discussed is IL6; the disease is rheumatoid arthritis.